Showing results (231-240 of 256) with videos related to
Sort By:
Pageof 26
Plos One|March 3, 2011
Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-AMasataka Fujiwara, Peishi Yan, Tomomi G Otsuji, et al.Clinical Neuropharmacology|September 21, 2018
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label TrialTsuyoshi Miyaoka, Misako Kanayama, Rei Wake, et al.Journal of Cancer Research and Clinical Oncology|July 14, 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancerYusuke Inoue, Naoki Inui, Masato Karayama, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2020
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective StudyYuzo Suzuki, Masato Karayama, Tomohiro Uto, et al.BMC Pulmonary Medicine|October 3, 2021
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysisKoichi Miyashita, Masato Karayama, Yusuke Inoue, et al.Respirology (Carlton, Vic.)|November 12, 2020
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trialTomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, et al.Clinical Lung Cancer|November 3, 2025
Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic TherapySuguru Kojima, Yusuke Inoue, Masato Karayama, et al.Journal for Immunotherapy of Cancer|July 27, 2023
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.BMC Pulmonary Medicine|October 8, 2024
Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.Oncotarget|September 16, 2015
Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter studyHideo Baba, Yoshifumi Baba, Shinji Uemoto, et al.Pageof 26